123 related articles for article (PubMed ID: 21301321)
1. The influence of cyclooxygenase-1 expression on the efficacy of cyclooxygenase-2 inhibition in head and neck squamous cell carcinoma cell lines.
Park SW; Kim HS; Choi MS; Kim JE; Jeong WJ; Heo DS; Sung MW
Anticancer Drugs; 2011 Jun; 22(5):416-23. PubMed ID: 21301321
[TBL] [Abstract][Full Text] [Related]
2. Differential effects between cyclooxygenase-2 inhibitors and siRNA on vascular endothelial growth factor production in head and neck squamous cell carcinoma cell lines.
Park SW; Kim HS; Hah JH; Kim KH; Heo DS; Sung MW
Head Neck; 2010 Nov; 32(11):1534-43. PubMed ID: 20222044
[TBL] [Abstract][Full Text] [Related]
3. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
[TBL] [Abstract][Full Text] [Related]
4. The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells.
Park SW; Heo DS; Sung MW
Cell Oncol (Dordr); 2012 Feb; 35(1):1-8. PubMed ID: 21656078
[TBL] [Abstract][Full Text] [Related]
5. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
Bran G; Götte K; Riedel K; Hörmann K; Riedel F
In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
[TBL] [Abstract][Full Text] [Related]
6. A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation.
Abrahao AC; Castilho RM; Squarize CH; Molinolo AA; dos Santos-Pinto D; Gutkind JS
Oral Oncol; 2010 Dec; 46(12):880-7. PubMed ID: 20951077
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation.
Hsu JY; Chang KY; Chen SH; Lee CT; Chang ST; Cheng HC; Chang WC; Chen BK
Oncotarget; 2015 Jan; 6(3):1723-39. PubMed ID: 25595899
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
9. Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways.
Hao Y; Xie T; Korotcov A; Zhou Y; Pang X; Shan L; Ji H; Sridhar R; Wang P; Califano J; Gu X
Int J Cancer; 2009 May; 124(9):2200-9. PubMed ID: 19123475
[TBL] [Abstract][Full Text] [Related]
10. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
Lim SC; Park SY; Do NY
Oncol Rep; 2003; 10(5):1073-9. PubMed ID: 12883661
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
Camacho M; León X; Fernández-Figueras MT; Quer M; Vila L
Head Neck; 2008 Sep; 30(9):1175-81. PubMed ID: 18642283
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone treatment inhibits VEGF production via suppression of STAT3 in a head and neck cancer cell line.
Shim SH; Hah JH; Hwang SY; Heo DS; Sung MW
Oncol Rep; 2010 Apr; 23(4):1139-43. PubMed ID: 20204302
[TBL] [Abstract][Full Text] [Related]
13. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
14. Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas.
Zhang W; Bhola N; Kalyankrishna S; Gooding W; Hunt J; Seethala R; Grandis JR; Siegfried JM
Mol Cancer Res; 2008 Dec; 6(12):1946-56. PubMed ID: 19074839
[TBL] [Abstract][Full Text] [Related]
15. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma.
Jaeckel EC; Raja S; Tan J; Das SK; Dey SK; Girod DA; Tsue TT; Sanford TR
Arch Otolaryngol Head Neck Surg; 2001 Oct; 127(10):1253-9. PubMed ID: 11587608
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.
Gallo O; Masini E; Bianchi B; Bruschini L; Paglierani M; Franchi A
Hum Pathol; 2002 Jul; 33(7):708-14. PubMed ID: 12196922
[TBL] [Abstract][Full Text] [Related]
17. RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma.
Arai A; Chano T; Futami K; Furuichi Y; Ikebuchi K; Inui T; Tameno H; Ochi Y; Shimada T; Hisa Y; Okabe H
Cancer Res; 2011 Jul; 71(13):4598-607. PubMed ID: 21571861
[TBL] [Abstract][Full Text] [Related]
18. Activation of COX-2/PGE2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production.
Alfajaro MM; Choi JS; Kim DS; Seo JY; Kim JY; Park JG; Soliman M; Baek YB; Cho EH; Kwon J; Kwon HJ; Park SJ; Lee WS; Kang MI; Hosmillo M; Goodfellow I; Cho KO
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881647
[TBL] [Abstract][Full Text] [Related]
19. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
Chen Z; Zhang X; Li M; Wang Z; Wieand HS; Grandis JR; Shin DM
Clin Cancer Res; 2004 Sep; 10(17):5930-9. PubMed ID: 15355926
[TBL] [Abstract][Full Text] [Related]
20. [Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
Li WZ; Wang XY; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):466-8. PubMed ID: 19304526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
